|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
Nose and throat carriage of MRSA and PVL-SA was low among recruits, despite a high incidence of SSTIs being reported, particularly cellulitis.
|
31357012 |
2020 |
|
Soft Tissue Infection
|
0.100 |
GeneticVariation
|
group |
BEFREE |
To overcome the increasing difficulties in the clinical management of SSTI due to MRSA, new prophylactic and therapeutic approaches are urgently needed and a preventive vaccine would be welcome.
|
31299217 |
2019 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
These infections were chiefly SSTIs, although urinary tract infections were also noted.Incidences of CO-MRSA blood-stream infections and outpatient skin and soft tissue infections have been increasing with time, except in Tasmania.
|
30805180 |
2019 |
|
Soft Tissue Infection
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The LA-S. aureus infected mice had decreased IL-1β protein levels compared with CA-MRSA-infected mice (p < 0.05), suggesting a suboptimal host response to LA-S. aureus SSTIs.
|
31043631 |
2019 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
Travel-associated CA-MRSA SSTI is a transmissible condition that leads to medical consultations and colonization of the infected host.
|
30315958 |
2019 |
|
Soft Tissue Infection
|
0.100 |
GeneticVariation
|
group |
BEFREE |
We conducted a study to determine in vitro susceptibility to vancomycin, daptomycin, linezolid and tedizolid in MRSA clinical isolates from adult patients with skin and soft tissue infections.
|
28432878 |
2017 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
Ceftaroline MICs were determined by reference BMD and by Etest for 1242 MSSA and MRSA isolates collected between February and May 2012 from adult patients with community-acquired pneumonia or complicated skin and soft tissue infections; tests were performed across six European laboratories.
|
27798220 |
2017 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
LA-MRSA CC398 caused 24.3 BSIs per 1000 SSTIs among people with no livestock contact, which is similar to the ratio observed for other types of MRSA.
|
28575216 |
2017 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
Meanwhile, case reports, case series and few studies have demonstrated the capability of LA-MRSA to cause all types of infections attributed to S. aureus in general including fatal courses.Human infections observed comprise e.g. bacteremia, pneumonia, osteomyelitis, endocarditis and many manifestations of skin and soft tissue infections.
|
26644311 |
2017 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
MRSA skin and soft-tissue infection (SSTI) incidence density decreased in adults (-3.5%; P<.001) and children (-2.9%; P=.004).
|
28903801 |
2017 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
Culturing of pus-producing SSTIs is crucial for providing adequate antimicrobials and elucidating MRSA epidemiology.
|
27677279 |
2017 |
|
Soft Tissue Infection
|
0.100 |
GeneticVariation
|
group |
BEFREE |
High burden of complicated skin and soft tissue infections in the Indigenous population of Central Australia due to dominant Panton Valentine leucocidin clones ST93-MRSA and CC121-MSSA.
|
28592231 |
2017 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
We previously showed that MRSA isolates from soft tissue infection (SSTI) produced significantly higher levels of PSM than MRSA isolates from hospital-acquired pneumonia (HAP) or infective endocarditis (IE).
|
26778460 |
2016 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
Staphylococcus aureus(CA-MRSA) isolates with skin and soft tissue infections (SSTIs).
|
27060098 |
2016 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
We collected MRSA strains isolated from outpatients with skin and soft-tissue infection (SSTI) at 107 medical facilities from 24 prefectures in 2010 and 2012.
|
25789579 |
2015 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
Our results suggested intrafamilial transmission of MRSA could be initial phenomenon of wide transmission in a community, therefore CA-MRSA SSTI in children and their family members should be monitored closely in order to notice the spread of highly pathogenic and transmittable strains.
|
26091885 |
2015 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
The predominance of SCCmec type IV or V CA-MRSA in soft tissue infection has also been indicated in Northern Taiwan.
|
26167865 |
2015 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
We characterized 45 non-duplicate CA-MRSA strains implicated mainly in skin and soft tissue infections (SSTIs) in a tertiary care hospital in Mysore, South India.
|
26044198 |
2015 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
Thirteen clinical CA-MRSA isolates recovered from patients presenting with skin and soft tissue infections to nine primary care clinics in the South Texas Ambulatory Research Network between 2010 and 2013.
|
25644979 |
2015 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
Two-hundred MRSA strains from inpatients with healthcare-associated (HA) and 100 MRSA strains from outpatients with community-associated (CA) skin and soft tissue infections (SSTIs) were tested for antimicrobial susceptibility, staphylococcal cassette chromosome mec (SCCmec) typing, Panton-Valentine leucocidin (PVL) toxin, seh and arcA genes.
|
24690229 |
2015 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
Tigecycline demonstrated comparable efficacy for treatment of MRSA soft tissue infections regardless of infection type, SCCmec, or PVL status.
|
24725736 |
2014 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
Compared to HA-MRSA-HO isolates, the CA-MRSA and HA-MRSA-CO isolates were associated with a higher proportion of skin and soft tissue infections (81.8% and 65.3% vs. 40.5%, p=0.001 and p=0.002) as well as lesser rate of resistance to ciprofloxacin (33.3% and 50.9% vs. 74.4%, p<0.001 and p=0.002), gentamicin (44.4% and 64.4% vs. 84.6%, p<0.001 and p=0.002), and trimethoprim/sulfamethoxazole (33.3% and 42.4% vs. 58.1%, p=0.02 and p=0.048), and a lower 30-day all-cause mortality rate (7.4% and 0% vs. 20.9%, p<0.001).
|
24961181 |
2014 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
After infection control measures and prolonged decontamination have been implemented with a high adherence, six patients remained sustained CA-MRSA USA300 carriers, including one who developed mupirocin resistance and six who experienced minor CA-MRSA-related SSTIs.
|
24816900 |
2014 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
Twenty MRSA isolates were detected from CAI, 17 were from skin and soft-tissue infections and 3 from other infections.
|
23731504 |
2013 |
|
Soft Tissue Infection
|
0.100 |
Biomarker
|
group |
BEFREE |
In particular, the USA300 epidemic clone has emerged and now represents the cause of as much as 98% of CA-MRSA skin and soft tissue infections in the United States.
|
23698534 |
2013 |